An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre

Journal of Neurology

Volumn 262, Issue 2, 2015, Pages 418-424

  Huda, S ^a,b   Wong, S H ^c   Pettingill, P ^b   O'Connell D ^a   Vincent, A ^b   Steiger, M ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Antibody; Autoimmunity; Limbic encephalitis; Peripheral nerve hyperexcitability; Voltage gated potassium channel complex

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER INCIDENCE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NERVE HYPEREXCITABILITY; PERIPHERAL NEUROPATHY; PHENOTYPE; POLYNEUROPATHY; POTASSIUM CHANNELOPATHY; PRIORITY JOURNAL; RASMUSSEN SYNDROME; RETROSPECTIVE STUDY; SHY DRAGER SYNDROME; TERTIARY CARE CENTER; BLOOD; CHANNELOPATHY; IMMUNOLOGY;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CHANNELOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED; RETROSPECTIVE STUDIES;

EID: 84925536076     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7588-0     Document Type: Article

References (17)

1. Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, Avoni P, McWilliam RC, Stephenson JB, Hanna MG, Kullmann DM, Spauschus A (2000) Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 48:647–656
2. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8:136–140
3. Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie NW, McWilliam RC, Stephenson JB, Kullmann DM, Hanna MG (1999) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122:817–825
4. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748
5. Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Jackson M, Vincent A (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73–78
6. Vincent A, Buckley C, Schott JM, Baker I, Dewar K, Detert N, Clover L, Parkinson A, Bien C, Omer S, Lang B, Rossor M, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712
7. Olberg H, Haugen M, Storstein A, Vedeler CA (2013) Neurological manifestations related to level of voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry 84:941–943
8. Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM (2014) Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 85:625–630
9. Klein CJ, Lennon VA, Aston PA, MCcKeon A, O’Toole O, Quek A, Pittock SJ (2013) Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 70:229–234
10. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895
11. Cancer Research UK (2014) Cancer incidence in the UK in 2011. http://publications.cancerresearchuk.org/downloads/Product/CS_REPORT_INCIDENCE.pdf. Accessed 25 Oct 2014
12. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81:1167–1169
13. Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M (2013) Autoantibodies to epilepsy-related LGI1 limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161–18174
14. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241–255
15. Fujita K, Yuasa T, Watanabe O, Takahashi Y, Hashiguchi S, Adachi K, Izumi Y, Kaji R (2012) Voltage-gated potassium channel complex antibodies in Creutzfeldt–Jakob disease. J Neurol 259:2249–2250
16. Angus-Leppan H, Rudge P, Mead S, Collinge J, Vincent A (2013) Autoantibodies in sporadic Creutzfeldt–Jakob disease. JAMA Neurol 70:919–992
17. Rossi M, Mead S, Collinge J, Rudge P, Vincent A (2014) Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt–Jakob disease. JNNP. doi:10.1136/jnnp-2014-308695